FDA-AACR-IASLC Workshop to Address Tobacco Use Assessment in Clinical Trials
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
Circulating tumor DNA (ctDNA) was first detected over 30 years ago, but its potential uses for cancer diagnosis and...
February is National Cancer Prevention Month. We recently had the opportunity to speak with American Association for Cancer Research...
There’s a quiet corner of the San Diego Convention Center where snacks and toys are plentiful, and naps are...
Today is International Day of Women and Girls in Science, a United Nations initiative aimed at encouraging full and...
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Despite considerable progress against cancer, the disease continues to take a huge toll on global health. Each year, approximately...
The new year began with the good news that death rates from cancer are continuing their steady decline. A...
Around 400 BC, the Greek physician Hippocrates is believed to have first described tumors as “cancer,” using the words...
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...